The Medicines Committee is a unique collaborative standing committee with membership split between the RCPCH and Neonatal and Paediatric Pharmacists Group (NPPG).
The Committee's key work areas are:
- Consultation - Responds to consultation documents from the Government and outside agencies, including the National Institute of Clinical Excellence (NICE)
- Lobbying - Advises and supports external agencies and parental bodies about the licensing, availability, use and surveillance of medicines in paediatric populations. This includes medicines used outside of the license, newly licensed products, unlicensed medicines for rare conditions and adverse reactions to medicines
- Education - Supports education training and research in the field of safe prescribing
The Committee also supports several organisations in the following ways:
- British National Formulary For Children (BNF-C) - Inputs into the policy issues surrounding the development of the BNF-C and supports the production of future editions. BNF-C information is available to most RCPCH members via Paediatric Care Online (PCO UK)
- Medicines for Children - Assists with the development of the Medicines for Children leaflets. These provide practical and reliable information, covering more than 100 medicines, and are accompanied by instructional films related to the use of medicines in children
- NIHR Clinical Research Network (CRN): Children Specialty - The Children Specialty is one of over 30 specialties in the NIHR, bringing together communities of clinical practice to provide national networks of research expertise, and working to support the implementation of research into NHS practice. The Medicines Committee supports the function of the NIHR-CRN: Children in relation to research opportunities and implications for practice
- Meds IQ - Provides input into the governance and management of Meds IQ, an online resource designed to improve medications safety in paediatric research and practice
Alerts and safety messages
There are no new alerts and safety messages relating to paediatric medicine. For the latest advice for medicines users, including children and young people, please see this month's Medicines and Healthcare Products Regulatory Agency (MHRA) Medicines Safety Update.
There are currently no consultations being responded to by the Medicines Committee.
For more information about the Medicines Committee please email: email@example.com